Towards Healthcare
Generic Drug CRO Market to Drive USD 11.73 Bn by 2034

Generic Drug CRO Market 2025 Expansion and Innovation Trends

According to market projections, the global generic drug CRO market, valued at USD 8.45 billion in 2024, is anticipated to reach USD 11.73 billion by 2034, growing at a CAGR of 3.36% over the next decade. The generic drug CRO market is growing due to increasing demand for affordable healthcare services and the expiration of patents on major medicines. North America is dominant in the market due to the rising aging population and well-established government system. 

Content

  • Last Updated: 17 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The generic drug CRO market in 2025 is valued at USD 8.74 billion and is projected to climb to USD 11.73 billion by 2034, with a CAGR of 3.36% over the forecast period.

North America is currently leading the generic drug CRO market due to a high concentration of major pharmaceutical companies and advanced healthcare infrastructure.

The generic drug CRO market includes five segments by service type, by dosage form, by end user, by business model, by technology/platform, and by region.

A generic medicine is a medicine that is developed to be the same as a medicine that has already been authorized. Its authorization is based on efficacy and safety data from studies on the authorized medicine.

Ministry of Health and Family Welfare, FDA, WHO, PIB, CDC.
Any Questions